Sidney Taurel
Sidney Taurel
Sidney Taurelis a Moroccan-born American businessman. He is the former Chairman and Chief Executive Officer of Eli Lilly and Company. He became chief executive officer in July 1998 and chairman of the board of directors on January 1, 1999. He was succeeded as chief executive officer by John C. Lechleiter on April 1, 2008. He now serves as an advisor at Moelis & Company...
combined continues dependent five fully growth introduced last less line major percent performance product products prozac rate sales
As our product line continues to become more diversified, we have become less dependent on Prozac performance. Major products introduced in the last five years accounted for fully one-third of our sales in 1999 and had a combined growth rate of 41 percent during the year.
bringing earnings half sales second stronger
As we expected, the second half of 2005 is bringing stronger sales and earnings growth,
data erosion months nearly product prozac sales severe
With nearly two months of Prozac sales data available, the erosion in prescriptions is the most severe ever for a blockbuster product in our industry,
commitment execution faster grow quarter rate reflect results sales strong
Our strong bottom-line results in the first quarter reflect the execution on our commitment to grow sales at a faster rate than our expenses.
existing extensions growth less line next overall product products prozac quarters recent rely sales several
Our overall growth for the next several quarters will be generated from newer product sales, line extensions of existing products and recent product launches, ... As a result, we will rely less on Prozac sales growth.
access affordable assistance earthquake ease employees ensure essential forward gave groups halt health hurricane improve offered patients save seniors share six spread stepped suffering urgent year
In a year of urgent needs, Lilly and its employees stepped forward with extraordinary efforts. To ease the suffering of hurricane and earthquake victims, we gave essential medicines, cash, and supplies. To ensure that seniors and low-income patients had affordable access to drugs, we offered six patient assistance programs. And to halt the spread of multi-drug-resistant tuberculosis, we partnered with the World Health Organizations and other groups to share expertise, improve treatment, and save lives.
fine hope push stopped
I hope they won't push too much farther. If they stopped right now, it'd be fine with me.
help means products weather
That means up to 10 products that will be launched between 2001 and 2004, which will help us weather the storm,
broad built business challenges charlie company financial help internal judgment past reputation sound steer strong
During his tenure, Charlie used his broad business experiences and sound judgment to help steer the company through many challenges over the past decade. Through Charlie's leadership, we have built a world-class financial organization and strengthened Lilly's reputation for sound financial operations, transparency in our financial reporting, and strong internal controls.
building importance launching pipeline quarter strong
While the first quarter was a challenging quarter, it underscores the importance of building a strong pipeline and effectively launching new products,
appeals asking case decision fails option supreme
We are asking for a rehearing on the decision by the appeals court, and if that fails we have the option of going to the Supreme Court, so the case is not over,
dose patient
the right dose of the right drug to the right patient at the right time.
address bring closely committing company continue deliver fda innovative medicines necessary order patients promise quickly resources work
I am committing all the necessary resources of the company to address these issues, ... We will continue to work closely with the FDA in order to deliver on our promise to bring these innovative new medicines to patients as quickly as possible.
destiny execute help structure
Now that we've done all this, our destiny is in our hands. It's up to us to perform. This new structure will help us better execute our strategy.